Watson Cheng

Watson Cheng has a diverse work experience history. From 2020 to the present, they served as the Vice President of Pharma PE and Royalty Investment at CBC Group. In this role, they led various initiatives including platform buyouts, strategic bolt-on M&A, and platform mergers. Prior to this, from 2016 to 2020, Watson worked at IQVIA as an Associate Principal, managing a team and focusing on new product launch strategy and commercial due diligence. Watson also held roles as an Engagement Manager, Senior Consultant, and Consultant at the same company. Before joining IQVIA, Watson was a Business Consultant at ZS Associates from 2015 to 2016. Watson began their career in the pharmaceutical industry as a Sales Representative at Roche Pharmaceuticals from 2012 to 2013. Watson also gained experience as a Professional Sales Representative at Merck Sharp & Dohme from 2010 to 2012. Watson started their career as a Pharmacy Intern at TAIPEI CITY HOSPITAL HO-PIN BRANCH in 2010 and worked as a Market Analyst (Part-time) at NOVA PHARMA & LIPOSOME BIOTECH CO. LTD. from 2007 to 2009.

Watson Cheng earned a Master of Business Administration (MBA) degree from the Texas McCombs School of Business from 2013 to 2015. Prior to that, they obtained a Bachelor of Science in Pharmacy from Taipei Medical University between 2006 and 2010. In addition, they hold a Pharmacist License in Taiwan, which they acquired in 2010.